Ghobrial, D.K.; El-Nikhely, N.; Sheta, E.; Ragab, H.M.; Rostom, S.A.F.; Saeed, H.; Wahid, A.
The Role of Pyrazolo[3,4-d]pyrimidine-Based Kinase Inhibitors in The Attenuation of CCl4-Induced Liver Fibrosis in Rats. Antioxidants 2023, 12, 637.
https://doi.org/10.3390/antiox12030637
AMA Style
Ghobrial DK, El-Nikhely N, Sheta E, Ragab HM, Rostom SAF, Saeed H, Wahid A.
The Role of Pyrazolo[3,4-d]pyrimidine-Based Kinase Inhibitors in The Attenuation of CCl4-Induced Liver Fibrosis in Rats. Antioxidants. 2023; 12(3):637.
https://doi.org/10.3390/antiox12030637
Chicago/Turabian Style
Ghobrial, Diana K., Nefertiti El-Nikhely, Eman Sheta, Hanan M. Ragab, Sherif A. F. Rostom, Hesham Saeed, and Ahmed Wahid.
2023. "The Role of Pyrazolo[3,4-d]pyrimidine-Based Kinase Inhibitors in The Attenuation of CCl4-Induced Liver Fibrosis in Rats" Antioxidants 12, no. 3: 637.
https://doi.org/10.3390/antiox12030637
APA Style
Ghobrial, D. K., El-Nikhely, N., Sheta, E., Ragab, H. M., Rostom, S. A. F., Saeed, H., & Wahid, A.
(2023). The Role of Pyrazolo[3,4-d]pyrimidine-Based Kinase Inhibitors in The Attenuation of CCl4-Induced Liver Fibrosis in Rats. Antioxidants, 12(3), 637.
https://doi.org/10.3390/antiox12030637
